National Vision Holdings, Inc.
EYE · XNASCIK 1710155fmd_1W2ET1Y8QP443865DGM5SPEST3Manufacturing · Ophthalmic GoodsTemplate: Standard
Coverage: Jan 04, 2015 to Oct 03, 2026, 44 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1,196 | 1,375 | 1,537 | 1,724 | 1,712 | 2,080 | 1,645 | 1,756 | 1,823 | 1,987 |
| Cost of revenue | 545 | 637 | 714 | – | – | – | – | – | – | – |
| Gross profit | 651 | 738 | 823 | – | – | – | – | – | – | – |
| Selling, general and administrative | 526 | 600 | 687 | 744 | 725 | 901 | 833 | 905 | 939 | 1,016 |
| Total operating expenses | 587 | 674 | 781 | 844 | 838 | 1,000 | 924 | 997 | 1,070 | 1,109 |
| Operating income | 64 | 64 | 42 | 74 | 87 | 175 | 53 | 24 | (10) | 59 |
| Interest expense | 39 | 56 | 37 | 33 | 48 | 26 | – | – | – | – |
| Other non-operating income (expense) | – | – | – | – | (48) | (26) | (0) | (14) | – | – |
| Income before taxes | 25 | 4 | 5 | 30 | 39 | 149 | 52 | 10 | (26) | 42 |
| Income tax expense | 12 | (39) | (19) | (2) | 2 | 21 | 16 | 6 | 1 | 12 |
| Net income from continuing operations | 13 | 43 | 24 | 33 | 36 | 128 | 37 | 4 | (27) | 30 |
| Net income | 13 | 43 | 24 | 33 | 36 | 128 | 42 | (66) | (28) | 30 |
| Net income to common shareholders | – | – | – | 33 | 36 | 138 | 42 | (66) | – | – |